Already approved drug avapritinib shows promise in treating high-grade gliomas

High-grade glioma, an aggressive form of pediatric and adult brain cancer, is challenging to treat given the tumor location, incidence of recurrence and difficulty for drugs to cross the blood-brain barrier.

Signal: Porosome files comprehensive patent for therapies to treat cystic fibrosis and other health conditions – Pharmaceutical Technology

The biopharma company has filed a comprehensive patent to address cystic fibrosis and other ailments. Image Credit: Zerbor/Shutterstock Porosome Therapeutics has announced a potentially novel

August 22, 2023

Improving COPD outcomes through enhanced inhaler education and technique

Inhaler misuse leading to inadequate medication delivery impacts a person’s ability to manage symptoms of chronic obstructive pulmonary disease (COPD), and additional education about proper

August 21, 2024

Niger becomes first African country to eliminate onchocerciasis

The World Health Organization (WHO) congratulates Niger for having met the criteria for onchocerciasis elimination, making it the fifth country globally and the first country

January 31, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.